Press Releases

NovaSignal Appoints Mark Laret, President and CEO of UCSF Health, to its Board of Directors

August 5, 2021

NovaSignal Corp. announced today that its board of directors has appointed Mark R. Laret as an independent director, effective August 5, 2021. Mr. Laret is president and chief executive officer of UCSF Health.

NovaSignal Launches Platform To Transform Cerebral Blood Flow Measurement

April 14, 2021

The NovaGuide™ 2 Intelligent Ultrasound and NovaGuide View cloud-based software make complex cerebral assessments easy to perform and enable faster time to treatment with on-demand access to exam data

Former Intel Chairman, Andy D. Bryant Joins NovaSignal’s Board of Advisors

January 26, 2021

Technology industry veteran, Andy D. Bryant, to help drive company growth and advise technology innovation

NovaSignal Appoints Former U.S. Surgeon General Dr. Richard Carmona to Board of Advisors

December 8, 2020

As NovaSignal extends the reach and impact of its solutions worldwide, the company grows its access to deep public health expertise with the appointment of Richard Carmona, the 17th Surgeon General of the United States, to the Board of Advisors

NovaSignal Appoints Lynne Doughtie to the Board of Advisors

December 8, 2020

As NovaSignal extends the reach and impact of its solutions worldwide, the company is adding to its capabilities and expertise with the appointment of Lynne Doughtie, former Chairman and CEO of KPMG LLP, to the Board of Advisors

NovaSignal Announces First Patient Enrolled in Innovative Clinical Trial

October 13, 2020

NovaSignal Corp., a medical technology and data company specializing in assessing cerebral blood flow, today announced enrollment of the first patient in its clinical trial evaluating the advantages of the NovaGuide Intelligent Ultrasound in detecting a patent foramen ovale (PFO) compared to traditional ultrasound methods.

NovaSignal Expands Global Footprint with India Entity

September 30, 2020

NovaSignal Corp., a medical technology and data company specializing in assessing cerebral blood flow, announced today its expansion into India.

NovaSignal Corp. and Nationwide Children’s Hospital Partner to Improve the Lives of Children with Sickle Cell Disease

September 23, 2020

Dr. Nicole O’Brien, a critical care physician and director of the Global Health Certificate Program at Nationwide Children’s, has spent the last six years working to understand and address acute neurologic illness and injury in children. Her years of research took her to subSaharan Africa, where up to 3% of births, or over 300,000 babies, are born with sickle cell disease each year.

NovaSignal Appoints Gayle Sheppard to the Advisory Board

September 10, 2020

NovaSignal Corp., a medical technology and data company specializing in assessing cerebral blood flow, announced today that Gayle Sheppard is joining the Advisory Board, effective Sep 7, 2020.

NovaSignal Appoints John Donovan, Former CEO of AT&T Communications, to its Board of Directors

August 27, 2020

NovaSignal Corp., a medical technology and data company specializing in assessing cerebral blood flow, announced today that its board of directors has appointed John M. Donovan as an independent director, effective Wednesday, August 26th. Donovan most recently served as CEO of AT&T Communications.

Novasignal’s Lucid™ Robotic System Used By Mount Sinai Health System Uncovers Possible Breakthrough In Patients With Covid-19

August 10, 2020

While monitoring these critically ill patients with the Lucid™ Robotic System, physicians discovered an overabundance of pulmonary shunting, a physical dysfunction whereby deoxygenated blood bypasses the normal circulatory system resulting in lower levels of oxygen in the blood and contributing to respiratory distress in patients with COVID-19.

Neural Analytics Rebrands Itself NovaSignal™

July 7, 2020

Medical technology and data company Neural Analytics, Inc. announced a name change and rebranding as NovaSignal Corp., representing its expansion into new markets and accelerated commercialization of its life-saving solutions that measure blood flow in the brain.

Neural Analytics Appoints Diane M. Bryant as Chairman and CEO

January 9, 2020

Neural Analytics, Inc., a medical robotics company developing and commercializing technologies to measure and track brain health, announced today it has appointed former Google Cloud COO Diane M. Bryant as Chairman and CEO, effective immediately. Leo Petrossian has resigned from his position as CEO and will be maintaining his company role as Co-Founder and President.